PACB Financials
Pacific Biosciences of California - Financial statements & key metrics
Stock Price
$1.28
Market Cap
$387.11M
P/E Ratio
-1.1
EPS
$-2.13
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-309.85M
EPS (Diluted)
$-1.59
Balance Sheet Highlights
Total Assets
$1.26B
Total Liabilities
$753.85M
Shareholders Equity
-
Cash & Equivalents
$55.37M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-206.06M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-100.9%
ROE
-205.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is PACB revenue?
View PACB's income statement for detailed revenue data.
Is PACB profitable?
PACB reported a loss of $309.85M in the most recent quarter.
What is PACB market cap?
PACB has a market capitalization of $387.11M, making it a small-cap stock.
Does PACB have debt?
View PACB's balance sheet for debt information.
What is PACB cash flow?
Cash flow data is available in the full financial statements.